These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9765604

  • 21. Ratiometric analysis of zidovudine (ZDV) incorporation by reverse transcriptases or polymerases via bio-orthogonal click chemistry.
    Koh M, Park J, An H, Park SB.
    Chem Commun (Camb); 2011 Jul 21; 47(27):7614-6. PubMed ID: 21660353
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y, Rochford G, Rigaud M, Essajee S, Pollack H, Krasinski K, Borkowsky W.
    Clin Infect Dis; 2001 Jul 01; 33(1):e3-7. PubMed ID: 11389511
    [Abstract] [Full Text] [Related]

  • 23. [Human immunodeficiency virus and antiretroviral therapy resistance].
    Quirós E, Torti C, Carosi G.
    Enferm Infecc Microbiol Clin; 2000 May 01; 18(5):234-7. PubMed ID: 10974768
    [No Abstract] [Full Text] [Related]

  • 24. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA.
    AIDS Clin Rev; 2000 May 01; ():139-91. PubMed ID: 10999220
    [No Abstract] [Full Text] [Related]

  • 25. An HIV reverse transcriptase-selective nucleoside chain terminator.
    Fraley AW, Chen D, Johnson K, McLaughlin LW.
    J Am Chem Soc; 2003 Jan 22; 125(3):616-7. PubMed ID: 12526645
    [Abstract] [Full Text] [Related]

  • 26. Failure of AZT: a molecular perspective.
    Hazuda D, Kuo L.
    Nat Med; 1997 Aug 22; 3(8):836-7. PubMed ID: 9256270
    [No Abstract] [Full Text] [Related]

  • 27. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L, Johnson M, Graham N, Shaefer M, St Clair M.
    J Hum Virol; 1999 Aug 22; 2(5):290-5. PubMed ID: 10551735
    [Abstract] [Full Text] [Related]

  • 28. [The issue of inhibitors of retroviral infections].
    Govorov VT, Chabanenko AI.
    Voen Med Zh; 2003 Aug 22; 324(4):53-5. PubMed ID: 12825369
    [No Abstract] [Full Text] [Related]

  • 29. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
    Jeeninga RE, Keulen W, Boucher C, Sanders RW, Berkhout B.
    Virology; 2001 May 10; 283(2):294-305. PubMed ID: 11336554
    [Abstract] [Full Text] [Related]

  • 30. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y, Vivet-Boudou V, Marquet R.
    Appl Microbiol Biotechnol; 2007 Jun 10; 75(4):723-37. PubMed ID: 17370068
    [Abstract] [Full Text] [Related]

  • 31. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    D'Cruz OJ, Uckun FM.
    J Antimicrob Chemother; 2006 Mar 10; 57(3):411-23. PubMed ID: 16431862
    [Abstract] [Full Text] [Related]

  • 32. [Resistance to nucleoside reverse transcriptase inhibitors].
    Leal M, Santamaría JM.
    Enferm Infecc Microbiol Clin; 2001 Feb 10; 19(Monografico):26-9. PubMed ID: 11428055
    [No Abstract] [Full Text] [Related]

  • 33. Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure.
    Rusconi S, De Pasquale MP, Milazzo L, Kurtagic S, Bulgheroni E, Citterio P, Galazzi M, La Seta Catamancio S, Galli M.
    Antivir Ther; 1998 Feb 10; 3(4):203-7. PubMed ID: 10682139
    [Abstract] [Full Text] [Related]

  • 34. Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase.
    Patel RV, Park SW.
    Bioorg Med Chem; 2015 Sep 01; 23(17):5247-63. PubMed ID: 26116177
    [Abstract] [Full Text] [Related]

  • 35. Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
    AIDS; 1998 Jul 30; 12(11):1259-65. PubMed ID: 9708404
    [No Abstract] [Full Text] [Related]

  • 36. [Resistance to antiretroviral drugs: a clinical, public health and health policy debate].
    Guerra Romero L, Parras Vázquez F.
    Med Clin (Barc); 2000 Oct 07; 115(11):428-30. PubMed ID: 11093847
    [No Abstract] [Full Text] [Related]

  • 37. [Zalcitabine].
    Enferm Infecc Microbiol Clin; 1997 Mar 07; 15(3):177-8. PubMed ID: 9235070
    [No Abstract] [Full Text] [Related]

  • 38. What's new in HIV.
    Morris-Jones S, Nelson MR.
    J Infect; 1999 Mar 07; 38(2):i-ii. PubMed ID: 10342641
    [No Abstract] [Full Text] [Related]

  • 39. New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.
    Huff JR.
    Bioorg Med Chem; 1999 Dec 07; 7(12):2667-9. PubMed ID: 10658570
    [No Abstract] [Full Text] [Related]

  • 40. A critical analysis of the pharmacology of AZT and its use in AIDS.
    Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D, Alphonso H, Miller T.
    Curr Med Res Opin; 1999 Dec 07; 15 Suppl 1():S1-45. PubMed ID: 11594171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.